Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis.

Simpson J, Castagno D, Doughty RN, Poppe KK, Earle N, Squire I, Richards M, Andersson B, Ezekowitz JA, Komajda M, Petrie MC, McAlister FA, Gamble GD, Whalley GA, McMurray JJ; Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC)..

Eur J Heart Fail. 2015 Nov;17(11):1182-91. doi: 10.1002/ejhf.346. Epub 2015 Sep 11.

2.

Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis.

Jackson CE, Castagno D, Maggioni AP, Køber L, Squire IB, Swedberg K, Andersson B, Richards AM, Bayes-Genis A, Tribouilloy C, Dobson J, Ariti CA, Poppe KK, Earle N, Whalley G, Pocock SJ, Doughty RN, McMurray JJ; Meta-Analysis Global Group in Chronic Heart Failure MAGGIC..

Eur Heart J. 2015 May 7;36(18):1106-14. doi: 10.1093/eurheartj/ehu490. Epub 2015 Jan 23. Review.

PMID:
25616644
3.

The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data.

Padwal R, McAlister FA, McMurray JJ, Cowie MR, Rich M, Pocock S, Swedberg K, Maggioni A, Gamble G, Ariti C, Earle N, Whalley G, Poppe KK, Doughty RN, Bayes-Genis A; Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)..

Int J Obes (Lond). 2014 Aug;38(8):1110-4. doi: 10.1038/ijo.2013.203. Epub 2013 Oct 31.

PMID:
24173404
4.

Known and missing left ventricular ejection fraction and survival in patients with heart failure: a MAGGIC meta-analysis report.

Poppe KK, Squire IB, Whalley GA, Køber L, McAlister FA, McMurray JJ, Pocock S, Earle NJ, Berry C, Doughty RN; Meta-Analysis Global Group in Chronic Heart Failure..

Eur J Heart Fail. 2013 Nov;15(11):1220-7. doi: 10.1093/eurjhf/hft101. Epub 2013 Jun 26.

5.

Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis(†): Meta-Analysis Global Group in Chronic heart failure (MAGGIC).

Rusinaru D, Tribouilloy C, Berry C, Richards AM, Whalley GA, Earle N, Poppe KK, Guazzi M, Macin SM, Komajda M, Doughty RN; MAGGIC Investigators..

Eur J Heart Fail. 2012 Oct;14(10):1139-46. Epub 2012 Jul 9.

6.

Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula.

McAlister FA, Ezekowitz J, Tarantini L, Squire I, Komajda M, Bayes-Genis A, Gotsman I, Whalley G, Earle N, Poppe KK, Doughty RN; Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) Investigators..

Circ Heart Fail. 2012 May 1;5(3):309-14. doi: 10.1161/CIRCHEARTFAILURE.111.966242. Epub 2012 Mar 22.

7.

Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis.

Martínez-Sellés M, Doughty RN, Poppe K, Whalley GA, Earle N, Tribouilloy C, McMurray JJ, Swedberg K, Køber L, Berry C, Squire I; Meta-Analysis Global Group In Chronic Heart Failure (MAGGIC)..

Eur J Heart Fail. 2012 May;14(5):473-9. doi: 10.1093/eurjhf/hfs026. Epub 2012 Mar 8.

8.

The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.

Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)..

Eur Heart J. 2012 Jul;33(14):1750-7. doi: 10.1093/eurheartj/ehr254. Epub 2011 Aug 6. Review.

PMID:
21821849
9.

Clinical outcome of patients with heart failure and preserved left ventricular function.

Gotsman I, Zwas D, Planer D, Azaz-Livshits T, Admon D, Lotan C, Keren A.

Am J Med. 2008 Nov;121(11):997-1001. doi: 10.1016/j.amjmed.2008.06.031.

PMID:
18954847
11.

Cytochrome p450 polymorphisms in geriatric patients: impact on adverse drug reactions--a pilot study.

Egger T, Dormann H, Ahne G, Pahl A, Runge U, Azaz-Livshits T, Neubert A, Criegee-Rieck M, Gassmann KG, Brune K.

Drugs Aging. 2005;22(3):265-72.

PMID:
15813658
12.

Readmissions and adverse drug reactions in internal medicine: the economic impact.

Dormann H, Neubert A, Criegee-Rieck M, Egger T, Radespiel-Tröger M, Azaz-Livshits T, Levy M, Brune K, Hahn EG.

J Intern Med. 2004 Jun;255(6):653-63.

13.

Use of complementary alternative medicine in patients admitted to internal medicine wards.

Azaz-Livshits T, Muszkat M, Levy M.

Int J Clin Pharmacol Ther. 2002 Dec;40(12):539-47.

PMID:
12503811
14.

Paroxetine associated hepatotoxicity: a report of 3 cases and a review of the literature.

Azaz-Livshits T, Hershko A, Ben-Chetrit E.

Pharmacopsychiatry. 2002 May;35(3):112-5. Review.

PMID:
12107856
15.

Compound cardiac toxicity of oral erythromycin and verapamil.

Goldschmidt N, Azaz-Livshits T, Gotsman, Nir-Paz R, Ben-Yehuda A, Muszkat M.

Ann Pharmacother. 2001 Nov;35(11):1396-9.

PMID:
11724091
16.

Mefloquine-induced acute hepatitis.

Gotsman I, Azaz-Livshits T, Fridlender Z, Muszkat M, Ben-Chetrit E.

Pharmacotherapy. 2000 Dec;20(12):1517-9.

PMID:
11130224
17.

Computerized survelliance of adverse drug reactions in hospital: pilot study.

Azaz-Livshits T, Levy M, Sadan B, Shalit M, Geisslinger G, Brune K.

Br J Clin Pharmacol. 1998 Mar;45(3):309-14.

18.

Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals.

Tegeder I, Levy M, Muth-Selbach U, Oelkers R, Neumann F, Dormann H, Azaz-Livshits T, Criegee-Rieck M, Schneider HT, Hahn E, Brune K, Geisslinger G.

Br J Clin Pharmacol. 1999 May;47(5):557-64.

19.

Computerized surveillance of adverse drug reactions in hospital: implementation.

Levy M, Azaz-Livshits T, Sadan B, Shalit M, Geisslinger G, Brune K.

Eur J Clin Pharmacol. 1999 Jan;54(11):887-92.

PMID:
10027665
20.

Tachycardia, orthostatic hypotension and profound weakness due to concomitant use of fluoxetine and nifedipine.

Azaz-Livshits TL, Danenberg HD.

Pharmacopsychiatry. 1997 Nov;30(6):274-5.

PMID:
9442553

Supplemental Content

Loading ...
Support Center